149 related articles for article (PubMed ID: 32958777)
1. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.
Koessinger AL; Koessinger D; Stevenson K; Cloix C; Mitchell L; Nixon C; Gomez-Roman N; Chalmers AJ; Norman JC; Tait SWG
Sci Rep; 2020 Sep; 10(1):15361. PubMed ID: 32958777
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.
Irtenkauf SM; Sobiechowski S; Hasselbach LA; Nelson KK; Transou AD; Carlton ET; Mikkelsen T; deCarvalho AC
Comp Med; 2017 Aug; 67(4):300-314. PubMed ID: 28830577
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
4. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts.
Benitez JA; Zanca C; Ma J; Cavenee WK; Furnari FB
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757276
[TBL] [Abstract][Full Text] [Related]
6. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models.
Chang E; Pohling C; Natarajan A; Witney TH; Kaur J; Xu L; Gowrishankar G; D'Souza AL; Murty S; Schick S; Chen L; Wu N; Khaw P; Mischel P; Abbasi T; Usmani S; Mallick P; Gambhir SS
J Neurooncol; 2016 Jan; 126(2):253-64. PubMed ID: 26650066
[TBL] [Abstract][Full Text] [Related]
7. Bioluminescent In Vivo Imaging of Orthotopic Glioblastoma Xenografts in Mice.
Frenster JD; Placantonakis DG
Methods Mol Biol; 2018; 1741():191-198. PubMed ID: 29392701
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
9. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
Upton DH; Ziegler DS; Tsoli M
Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an orthotopic glioblastoma mouse model for preclinical studies.
Iturrioz-Rodríguez N; Piccardi F; Bertorelli R; Ciofani G
Methods Cell Biol; 2024; 185():49-65. PubMed ID: 38556451
[TBL] [Abstract][Full Text] [Related]
11. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
13. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
Hashizume R; Gupta N; Berger MS; Banerjee A; Prados MD; Ayers-Ringler J; James CD; VandenBerg SR
Neuro Oncol; 2010 Apr; 12(4):366-76. PubMed ID: 20308314
[TBL] [Abstract][Full Text] [Related]
14. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
15. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
[TBL] [Abstract][Full Text] [Related]
16. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
[TBL] [Abstract][Full Text] [Related]
17. Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient.
Larsson S; Wenger A; Dósa S; Sabel M; Kling T; Carén H
Carcinogenesis; 2018 Oct; 39(10):1304-1309. PubMed ID: 29982329
[TBL] [Abstract][Full Text] [Related]
18. A novel technique of serial biopsy in mouse brain tumour models.
Rogers S; Hii H; Huang J; Ancliffe M; Gottardo NG; Dallas P; Lee S; Endersby R
PLoS One; 2017; 12(4):e0175169. PubMed ID: 28394918
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.
Baumann BC; Dorsey JF; Benci JL; Joh DY; Kao GD
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051742
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]